4.1 Article

Toxoplasma gondii is capable of exogenous folate transport -: A likely expansion of the BT1 family of transmembrane proteins

期刊

MOLECULAR AND BIOCHEMICAL PARASITOLOGY
卷 144, 期 1, 页码 44-54

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molbiopara.2005.07.006

关键词

Apicomplexa; intracellular parasitism; BT1; membrane transporter; folate metabolism; folic acid

资金

  1. NIAID NIH HHS [AI 44630, AI05093, T32 AI07404, R01 AI46416, 1R0AI045806-01A1] Funding Source: Medline
  2. NIGMS NIH HHS [T32 GM07324, GMO7205] Funding Source: Medline
  3. Wellcome Trust Funding Source: Medline

向作者/读者索取更多资源

Folates are key elements in eukaryotic biosynthetic processes. The protozoan parasite Toxoplasma gondii possesses the enzymes necessary for de novo folate synthesis and has been suggested to lack alternative mechanisms for folate acquisition. In this paper, we present a different view by providing evidence that Toxoplasma is capable of salvaging exogenous folates. By monitoring uptake of radiolabeled folates by parasites in axenic conditions, our studies revealed a common folate transporter that has a high affinity for folic, acid. Transport of this compound across the parasite plasma membrane is rapid, biphasic, temperature dependent, bi-directional, concentration dependent and specific. In addition, morphological evidence demonstrates that fluorescent methottexate, a folate analog, is internalized by Toxoplasma and shows localization reminiscent to the mitochondrion. The presence of putative folate transporter genes in the Toxoplasma genome, which are homologous to the BT1 family of proteins, suggests that Toxoplasma may encode proteins involved in folate transport. Interestingly, genome analysis suggests that the BT1 family of proteins exists not only in Toxoplasma, but in other Apicomplexan parasites as well. Altogether, our results not only have implications for current therapeutic regimens against T gondii, but they also allude that the folate transport mechanism may represent a novel Apicomplexan target for the development of new drugs. (D 2005 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据